Metastatic renal cell carcinoma (mRCC) primary refractory patients to first-line IO-TKI and IO-IO combinations (Meet-URO 33 analysis).

Authors: Davide Bimbatti, Alessio Signori, Sebastiano Buti, Francesca Vignani, Federico Paolieri, Cinzia Ortega, Lucia Fratino, Emilia Cocorocchio, Cristian Lolli, Claudia Mucciarini, Martina Buffoni, Diego Zara, Valeria Sardaro, Debora D'Ausilio, Stefania Di Girolamo, Claudia Mosillo, Letizia Galeasso, Anna Tortorella, Michele Maffezzoli, Sara Elena Rebuzzi

Published: 2025-02-18

DOI: 10.1200/jco.2025.43.5_suppl.499

Source: Full article


Abstract

499